An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder

Clinical trial NCT07693608 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07693608
Sponsor: University of Texas Southwestern Medical Center
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Methamphetamine Use Disorder Cocaine Use Disorder Stimulant Use Disorders

Start date: 2026-08-19
Primary completion: 2030-02-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.